Little Green Pharma Future Growth

Future criteria checks 4/6

Little Green Pharma is forecast to grow earnings and revenue by 110.1% and 16.3% per annum respectively. EPS is expected to grow by 109.8% per annum. Return on equity is forecast to be 0.1% in 3 years.

Key information

110.1%

Earnings growth rate

109.8%

EPS growth rate

Pharmaceuticals earnings growth43.7%
Revenue growth rate16.3%
Future return on equity0.1%
Analyst coverage

Low

Last updated17 Apr 2024

Recent future growth updates

Recent updates

Earnings and Revenue Growth Forecasts

CHIA:LGP - Analysts future estimates and past financials data (AUD Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
3/31/2026360121
3/31/202530-3-2-11
3/31/202426-8-10N/A
12/31/202324-6-3-1N/A
9/30/202323-3-5-2N/A
6/30/202322-6-8-4N/A
3/31/202320-9-12-7N/A
3/31/202214-24-33-23N/A
12/31/20211113-21-14N/A
9/30/2021918-14-10N/A
6/30/2021722-6-5N/A
3/31/202169-7-4N/A
12/31/20205-3-7-2N/A
9/30/20204-6-10-4N/A
6/30/20202-9-13-6N/A
3/31/20202-9-11-6N/A
12/31/20191-9-8-5N/A
9/30/20191-7-6-4N/A
6/30/20190-6-4-3N/A
6/30/20180-4-2-2N/A
6/30/201700N/A0N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: LGP is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (2.6%).

Earnings vs Market: LGP is forecast to become profitable over the next 3 years, which is considered above average market growth.

High Growth Earnings: LGP is expected to become profitable in the next 3 years.

Revenue vs Market: LGP's revenue (16.3% per year) is forecast to grow faster than the Australian market (5.7% per year).

High Growth Revenue: LGP's revenue (16.3% per year) is forecast to grow slower than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: LGP's Return on Equity is forecast to be low in 3 years time (0.1%).


Discover growth companies